Concurrent Endometrial Carcinoma in Patients with a Curettage Diagnosis of Endometrial Hyperplasia

Concurrent Endometrial Carcinoma in Patients with a Curettage Diagnosis of Endometrial Hyperplasia

Endometrial hyperplasia is considered a precursor of endometrial carcinoma, but concurrent endometrial carcinoma in patients with endometrial hyperplasia is seen frequently. Our aim was to examine the risk factors for coexisting endometrial carcinoma in patients with endometrial hyperplasia. Methods...

Full description

Bibliographic Details
Main Authors:	Yu-Li Chen, Wen-Fang Cheng, Ming-Chieh Lin, Chia-Yen Huang, Chang-Yao Hsieh, Chi-An Chen
Format:	Article
Language:	English
Published:	Elsevier 2009-06-01
Series:	Journal of the Formosan Medical Association
Subjects:	endometrial carcinoma endometrial hyperplasia hysterectomy
Online Access:	http://www.sciencedirect.com/science/article/pii/S092966460960098X

Similar Items

Concurrent endometrial intraepithelial carcinoma (EIC) and endometrial hyperplasia
by: Steven Wang, MD, et al.
Published: (2015-03-01)

Aspiration biopsy versus dilatation and curettage for endometrial hyperplasia prior to hysterectomy
by: Woo Yeon Hwang, et al.
Published: (2021-01-01)

Liquid-based endometrial cytology associated with curettage in the investigation of endometrial carcinoma in postmenopausal women
by: Ke Ma, et al.
Published: (2016-12-01)

Trans-vaginal sono-elastography in the differentiation of endometrial hyperplasia and endometrial carcinoma
by: Mahmoud Abdel Latif, et al.
Published: (2016-09-01)

Risk of endometrial cancer in patients with a preoperative diagnosis of atypical endometrial hyperplasia treated with total laparoscopic hysterectomy
by: Katsutoshi Oda, et al.
Published: (2016-05-01)

Diagnosis of endometrial hyperplasia in routine gynecological practice
by: Ye. M. Poliakova, et al.
Published: (2019-02-01)

Study of the efficacy of pipelle biopsy technique to diagnose endometrial diseases in abnormal uterine bleeding
by: C Raja Ilavarasi, et al.
Published: (2019-01-01)

Immunohistochemical expression of estrogen and progesterone receptors in endometrial hyperplasia and endometrioid carcinoma
by: Sarmadi S, et al.
Published: (2012-06-01)

Results of surgical treatment of atypical endometrial hyperplasia
by: O. A. Gornykh, et al.
Published: (2014-07-01)

Concordance between the Hysteroscopic Diagnosis of Endometrial Hyperplasia and Histopathological Examination
by: Pasquale De Franciscis, et al.
Published: (2019-10-01)

The incidence rates of endometrial hyperplasia and endometrial cancer: a four-year population-based study
by: Jin-Sung Yuk
Published: (2016-08-01)

Hyperplasia and endometrial precancer
by: O. A. Gornikh, et al.
Published: (2014-08-01)

Prevalence of Co-existing Endometrial Carcinoma in Patients with Preoperative Diagnosis of Endometrial Hyperplasia
by: Pinar Kadirogullari, et al.
Published: (2015-10-01)

Risk factors of endometrial cancer in patients with endometrial hyperplasia: implication for clinical treatments
by: Jie Zhao, et al.
Published: (2021-08-01)

Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia
by: Toshiya Matsuzaki, et al.
Published: (2018-07-01)

Does Preoperative Diagnosis of Endometrial Hyperplasia Necessitate Intraoperative Frozen Section Consultation?
by: Gokhan Boyraz, et al.
Published: (2016-12-01)

Theresults of Computer Morphometryusedin Endometrial Hyperplasia
by: Yu Yu Tabakman, et al.
Published: (2013-06-01)

Livin/BIRC7 gene expression as a possible diagnostic biomarker for endometrial hyperplasia and carcinoma
by: Basma K. Elmekkawy, et al.
Published: (2021-09-01)

Non-atypical endometrial hyperplasia: risk factors for occult endometrial atypia and malignancy in patients managed with hysterectomy
by: Lee Shi Hui, et al.
Published: (2021-05-01)

THE RESULTS OF COMPUTER MORPHOMETRY USED IN ENDOMETRIAL HYPERPLASIA
by: Yu. Yu. Tabakman, et al.
Published: (2016-06-01)

MOLECULAR PROFILES OF ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA
by: S. A. Levakov, et al.
Published: (2018-08-01)

Influence of obesity on the development of endometrial hyperplasia in women of all ages
by: О. О. Єфіменко, et al.
Published: (2018-10-01)

<i>Pyruvate Kinase M2</i> Expression: A Potential Metabolic Biomarker to Differentiate Endometrial Precancer and Cancer That Is Associated with Poor Outcomes in Endometrial Carcinoma
by: Yu-Ju Lai, et al.
Published: (2019-11-01)

Diagnostic Value of Cytology in Detecting Endometrial Hyperplasia and Endometrial and Ovarian Cancers in Patients Undergoing Hysterectomy or Salpingo-Oophorectomy
by: Tajossadat Allameh, et al.
Published: (2019-01-01)

To the question of the pathogenesis of endometrial hyperplasia
by: A. Kh. Bishtavi, et al.
Published: (2014-07-01)

Evaluation of Diagnostic Efficacy of Pipelle Endometrial Sampling in Abnormal Uterine Bleeding
by: ABILASH SASIDHARANNAIR CHANDRAKUMARI, et al.
Published: (2018-05-01)

Serum and tissue angiogenin in patients with endometrial hyperplasia
by: Mohamed Abelsalam Mohamed, et al.
Published: (2010-10-01)

Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management
by: Oroma Nwanodi
Published: (2017-07-01)

Proteasome activity and subunit composition in endometrial hyperplasia and cancer
by: L. V. Spirina, et al.
Published: (2014-08-01)

What is the impact of radical hysterectomy on endometrial cancer with cervical involvement?
by: Salim Abraham Barquet-Muñoz, et al.
Published: (2020-05-01)

New classification system of endometrial hyperplasia WHO 2014 and its clinical implications
by: Katarzyna Sobczuk, et al.
Published: (2017-10-01)

Histological and immunohistochemical evaluation of leiomyoma and endometrial tissue in patients with uterine leiomyoma and endometrial hyperplasia
by: Potapov V.A., et al.
Published: (2014-03-01)

ENDOMETRIAL HYPERPLASIA: CONTROVERSIAL ISSUES OF PATHOGENESIS AND THERAPY
by: Yu. Yu. Tabakman, et al.
Published: (2016-10-01)

Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing Therapy
by: Junyu Chen, et al.
Published: (2021-09-01)

Efficacy of the LNG-IUS for treatment of endometrial hyperplasia and early stage endometrial cancer: Can biomarkers predict response?
by: Molly Dore, et al.
Published: (2021-05-01)

The retrospective analysis results of the endometrial tissue pathological conditions development
by: V. V. Artyomenko, et al.
Published: (2020-11-01)

COMBINED HORMONOTHERAPY WITH GNRG ANALOGUE AND INTRAUTERINE LEVONORGESTREL-RELEASING SYSTEM OF ATYPICAL ENDOMETRIAL HYPERPLASIA AND WELL-DIFFERENTIATED ENDOMETRIAL CARCINOMA: PROSPECTIV PILOT RESEARCH
by: A. I. Pashov, et al.
Published: (2012-05-01)

Results of histopathological findings of endometrial changes
by: Todorović Nada 1, et al.
Published: (2002-01-01)

Endometrial thickness cut-off value by transvaginal ultrasonography for screening of endometrial pathology in premenopausal and postmenopausal women
by: Yu Ran Park, et al.
Published: (2019-11-01)

Role of Liquid-based Cytology and Cell Block in the Diagnosis of Endometrial Lesions
by: Hui Zhang, et al.
Published: (2016-01-01)